US EditionHigher-Dose Semaglutide Achieves Significant Weight Reduction in Adults with Obesity
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Higher Doses of Semaglutide Linked to Weight Loss and Improved Health in Adults with Obesity
A recent study has found that higher doses of semagluti […] The post Higher Doses of Semaglutide Linked to Weight Loss and Improved Health in Adults with Obesity first appeared on GeneOnline News. The post Higher Doses of Semaglutide Linked to Weight Loss and Improved Health in Adults with Obesity appeared first on GeneOnline News.
Obesity in menopause represents a growing challenge in women due to hormonal changes, redistribution of body fat and increased cardiometabolic risk. With the arrival of GLP-1 receptor agonist drugs, such as semaglutide, important opportunities arise for their treatment, but also questions about their safety, loss of muscle mass and the need for a comprehensive approach that combines medication with healthy lifestyles. Therefore, two experts have…
Double benefit: Weight loss injections such as Wegovy, Ozempic or Mounjaro not only help against diabetes and obesity, they also protect against heart attack and stroke, as one study shows. Thus, the Ozempic active substance semaglutide reduces the risk of such severe cardiovascular diseases in diabetics by 18 percent, the Mounjaro active substance tirzepatide by around 13 percent. This protective effect is independent of weight loss, as researc…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
